RU2011136111A - METHOD FOR SELECTING A THERAPY SCHEME FOR PATIENTS WITH ACTION DISEASE - Google Patents
METHOD FOR SELECTING A THERAPY SCHEME FOR PATIENTS WITH ACTION DISEASE Download PDFInfo
- Publication number
- RU2011136111A RU2011136111A RU2011136111/15A RU2011136111A RU2011136111A RU 2011136111 A RU2011136111 A RU 2011136111A RU 2011136111/15 A RU2011136111/15 A RU 2011136111/15A RU 2011136111 A RU2011136111 A RU 2011136111A RU 2011136111 A RU2011136111 A RU 2011136111A
- Authority
- RU
- Russia
- Prior art keywords
- dia
- treatment
- laser therapy
- endorphins
- cortisol
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 4
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 claims abstract 17
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims abstract 8
- 238000002647 laser therapy Methods 0.000 claims abstract 8
- 102000009025 Endorphins Human genes 0.000 claims abstract 6
- 108010049140 Endorphins Proteins 0.000 claims abstract 6
- 210000002381 plasma Anatomy 0.000 claims abstract 6
- 208000002874 Acne Vulgaris Diseases 0.000 claims abstract 4
- 102000007330 LDL Lipoproteins Human genes 0.000 claims abstract 4
- 108010007622 LDL Lipoproteins Proteins 0.000 claims abstract 4
- 206010000496 acne Diseases 0.000 claims abstract 4
- 229960000890 hydrocortisone Drugs 0.000 claims abstract 4
- 238000011269 treatment regimen Methods 0.000 claims 1
Landscapes
- Radiation-Therapy Devices (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Способ прогнозирования эффективности дополнительного включения лазеротерапии в схему лечения пациентов с угревой болезнью, заключающийся в использовании регрессионного уравнения: К=-8,03328-0,0710001·кортизол-0,334017·эндорфины+0,0526548·ЛГШП+1,31453·ДИА, где К- коэффициент эффективности динамики дерматологического индекса акне (ДИА), кортизол - уровень кортизола в плазме крови до начала лечения, эндорфины - уровень эндорфинов в плазме крови до начала лечения, ЛПНП - уровень липопротеинов низкой плотности в плазме крови до начала лечения, ДИА- значение индекса ДИА до начала лечения; если Ксоставляет 6,6 и менее, то дополнительное назначение лазеротерапии в комплексном лечении малоэффективно - не более 50% улучшения ДИА в процессе лечения; если Кболее 6,6, но менее 7,9, то назначение лазеротерапии средне эффективно - прогнозируют снижение индекса ДИА в процессе лечения от 50 до 75%; если Ксоставляет 7,9 и более, то дополнительное назначение лазеротерапии по прогнозу будет сопровождаться динамикой снижения ДИА в процессе лечения более чем на 75%.A method for predicting the effectiveness of the additional inclusion of laser therapy in the treatment scheme for patients with acne, which consists in using the regression equation: K = -8.03328-0.0710001 · cortisol-0.334017 · endorphins + 0.0526548 · LGSH + 1.31453 · DIA where K is the efficiency coefficient of the dynamics of the dermatological index of acne (DIA), cortisol is the level of cortisol in the blood plasma before treatment, endorphins is the level of endorphins in the blood plasma before treatment, LDL is the level of low density lipoproteins in the blood plasma before treatment, DIA - value in dex DIA before treatment; if X is 6.6 or less, then the additional purpose of laser therapy in complex treatment is ineffective - no more than 50% improvement in DIA during treatment; if more than 6.6, but less than 7.9, then the appointment of laser therapy is moderately effective - they predict a decrease in the DIA index during treatment from 50 to 75%; if X is 7.9 or more, then the additional appointment of laser therapy according to the forecast will be accompanied by a dynamics of a decrease in DIA in the course of treatment by more than 75%.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2011136111/15A RU2499990C2 (en) | 2011-08-30 | 2011-08-30 | Method for choosing therapeutic regimen for patients suffering acne |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2011136111/15A RU2499990C2 (en) | 2011-08-30 | 2011-08-30 | Method for choosing therapeutic regimen for patients suffering acne |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2011136111A true RU2011136111A (en) | 2013-03-10 |
| RU2499990C2 RU2499990C2 (en) | 2013-11-27 |
Family
ID=49123100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011136111/15A RU2499990C2 (en) | 2011-08-30 | 2011-08-30 | Method for choosing therapeutic regimen for patients suffering acne |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2499990C2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2230554C2 (en) * | 2002-05-07 | 2004-06-20 | Глубокова Ирина Борисовна | Method for treating normo-atrophic scars with mechanic dermabrasion by applying combined collagen covering with antimicrobial preparation |
| US20100003315A1 (en) * | 2008-07-02 | 2010-01-07 | Willeford Kenneth L | Method and Composition for the Treatment of Skin Conditions |
-
2011
- 2011-08-30 RU RU2011136111/15A patent/RU2499990C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2499990C2 (en) | 2013-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2548508T3 (en) | Disease treatment methods | |
| EA201390762A1 (en) | NEW BIOMARKERS TO PREDICT THE OUTCOME OF ANTICATIVE IMMUNOTHERAPY | |
| BR112013030606A2 (en) | biomarkers for hedgehog inhibitor therapy | |
| WO2012092364A3 (en) | Method for sympathetic rebalancing of patient | |
| BR112014005427A2 (en) | method deployed by a computing device | |
| BR112015031542A2 (en) | cancer patient reaction prediction methods, cancer treatment method, treatment reaction prediction kit and innovative processes, methods and uses | |
| FI20115401A7 (en) | System and method for providing exercise in playing a music instrument | |
| AR090040A1 (en) | METHODS AND KITS FOR THE FORECAST OF COLORRECTAL CANCER | |
| NZ630421A (en) | Biomarkers predictive for clinical response for glatiramer acetate | |
| UA118658C2 (en) | Diagnostic method for predicting response to tnf? inhibitor | |
| NZ701652A (en) | Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression | |
| EP2533788A4 (en) | Stable solution | |
| EA201401201A1 (en) | METHOD | |
| BR112015004653A2 (en) | cancer diagnostic and therapeutic method of target molecules expressed in cancer stem cells | |
| MX2013015146A (en) | Predictive biomarker of survival in the treatment of renal cell carcinoma. | |
| RU2011136111A (en) | METHOD FOR SELECTING A THERAPY SCHEME FOR PATIENTS WITH ACTION DISEASE | |
| RU2008150292A (en) | METHOD FOR PRODUCING THE TECHNETSIA-99m CHROMATOGRAPHIC GENERATOR FROM MOLYBDENE-98 IRRADIATED BY NEUTRONS | |
| MX2015009726A (en) | Method for predicting the onset of extrapyramidal symptoms (eps) induced by an antipsychotic-based treatment. | |
| WO2012138740A3 (en) | Risk analysis for disease development | |
| Wang et al. | Effect of moderate acupuncture-stimulation of" Taichong"(LR 3) on blood pressure and plasma endothelin-1 levels in spontaneous hypertension rats | |
| Dames et al. | Intelligibility of children with bilateral and unilateral cleft lip and palate | |
| Mori | Linguistic variation in legal Maltese: EU directives compared to national laws | |
| Faustini et al. | CD19+ ZAP70+ B cells value at baseline predicts response at T6 to BCDT (B cell depletion therapy). Recovery is mainly characterized by the appearance of naïve activated B cells and ZAP-70 positive B cells | |
| Scandizzo et al. | Public investment management: Linking global trends to national experiences | |
| Tuffarelli et al. | Branch duct intraductal papillary mucinous neoplasm: validation of Fukuoka 2012 guidelines using a systematic review and meta-analysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20131027 |